<table id="table14" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 14: Drug Interactions: Pharmacokinetic Parameters for Darunavir in the Presence of Co-administered Drugs</caption>
<col align="left" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="5%"></col>
<col align="center" span="1" valign="top" width="5%"></col>
<col align="center" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="15%"></col>
<tbody>
<tr>
<th colspan="1">Co-Administered Drug</th>
<th colspan="2">Dose/Schedule</th>
<th colspan="1">N</th>
<th colspan="1">PK</th>
<th colspan="3">LS Mean Ratio (90% CI) of <content stylecode="underline">Darunavir</content> Pharmacokinetic Parameters With/Without Co-administered Drug<br/> No Effect =1.00</th>
</tr>
<tr>
<th colspan="1">Co-Administered Drug</th>
<th colspan="1">Darunavir/<br/>ritonavir</th>
<th colspan="1">C<sub>max</sub>
</th>
<th colspan="1">AUC</th>
<th colspan="1">C<sub>min</sub>
</th>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With Other HIV Protease Inhibitors</content>
</td>
</tr>
<tr>
<td>Atazanavir</td>
<td>300 mg q.d.<linkhtml href="#footnote-1">*</linkhtml>
</td>
<td>400/100 mg b.i.d. <linkhtml href="#footnote-2">†</linkhtml>
</td>
<td>13</td>
<td>↔</td>
<td>1.02<br/>(0.96–1.09)</td>
<td>1.03<br/>(0.94–1.12)</td>
<td>1.01<br/>(0.88–1.16)</td>
</tr>
<tr>
<td>Indinavir</td>
<td>800 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>9</td>
<td>↑</td>
<td>1.11<br/>(0.98–1.26)</td>
<td>1.24<br/>(1.09–1.42)</td>
<td>1.44<br/>(1.13–1.82)</td>
</tr>
<tr>
<td>Lopinavir/ Ritonavir</td>
<td>400/100 mg b.i.d.</td>
<td>1200/100 mg b.i.d.<linkhtml href="#footnote-3">‡</linkhtml>
</td>
<td>14</td>
<td>↓</td>
<td>0.79<br/>(0.67–0.92)</td>
<td>0.62<br/>(0.53–0.73)</td>
<td>0.49<br/>(0.39–0.63)</td>
</tr>
<tr>
<td></td>
<td>533/133.3 mg b.i.d.</td>
<td>1200 mg b.i.d.<footnoteref idref="t12ft3"></footnoteref>
</td>
<td>15</td>
<td>↓</td>
<td>0.79<br/>(0.64–0.97)</td>
<td>0.59<br/>(0.50–0.70)</td>
<td>0.45<br/>(0.38–0.52)</td>
</tr>
<tr>
<td>Saquinavir hard gel capsule<br/>
</td>
<td>1000 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>14</td>
<td>↓</td>
<td>0.83<br/>(0.75–0.92)</td>
<td>0.74<br/>(0.63–0.86)</td>
<td>0.58<br/>(0.47–0.72)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With Other  HIV Antiretrovirals</content>
</td>
</tr>
<tr>
<td>Didanosine</td>
<td>400 mg q.d.</td>
<td>600/100 mg b.i.d.</td>
<td>17</td>
<td>↔</td>
<td>0.93<br/>(0.86–1.00)</td>
<td>1.01<br/>(0.95–1.07)</td>
<td>1.07<br/>(0.95–1.21)</td>
</tr>
<tr>
<td>Efavirenz</td>
<td>600 mg q.d.</td>
<td>300/100 mg b.i.d.</td>
<td>12</td>
<td>↓</td>
<td>0.85<br/>(0.72–1.00)</td>
<td>0.87<br/>(0.75–1.01)</td>
<td>0.69<br/>(0.54–0.87)</td>
</tr>
<tr>
<td>Etravirine</td>
<td>200 mg b.i.d.</td>
<td>600/100 mg b.i.d.</td>
<td>15</td>
<td>↔</td>
<td>1.11<br/>(1.01–1.22)</td>
<td>1.15<br/>(1.05–1.26)</td>
<td>1.02<br/>(0.90–1.17)</td>
</tr>
<tr>
<td>Nevirapine</td>
<td>200 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>8</td>
<td>↑</td>
<td>1.40 <linkhtml href="#footnote-4">§</linkhtml>
<br/>(1.14–1.73)</td>
<td>1.24 <footnoteref idref="t12ft4"></footnoteref>
<br/>(0.97–1.57)</td>
<td>1.02 <footnoteref idref="t12ft4"></footnoteref>
<br/>(0.79–1.32)</td>
</tr>
<tr>
<td>Rilpivirine</td>
<td>150 mg q.d.</td>
<td>800/100 mg q.d.</td>
<td>15</td>
<td>↔</td>
<td>0.90 <br/>(0.81–1.00)</td>
<td>0.89 <br/>(0.81–0.99)</td>
<td>0.89 <br/>(0.68–1.16)</td>
</tr>
<tr>
<td>Tenofovir Disoproxil Fumarate</td>
<td>300 mg q.d.</td>
<td>300/100 mg b.i.d.</td>
<td>12</td>
<td>↑</td>
<td>1.16<br/>(0.94–1.42)</td>
<td>1.21<br/>(0.95–1.54)</td>
<td>1.24<br/>(0.90–1.69)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With HCV NS3-4A Protease Inhibitors</content>
</td>
</tr>
<tr>
<td>Boceprevir<linkhtml href="#footnote-5">¶</linkhtml>
</td>
<td>800 mg three times daily</td>
<td>600/100 mg b.i.d.</td>
<td>11</td>
<td>↓</td>
<td>0.64<br/>(0.58–0.71)</td>
<td>0.56<br/>(0.51–0.61)</td>
<td>0.41<br/>(0.38–0.45)</td>
</tr>
<tr>
<td>Telaprevir</td>
<td>750 mg every 8 hours<br/>
<br/>1125 mg every 12 hours</td>
<td>600/100 mg b.i.d.<br/>
<br/>
<br/>600/100 mg b.i.d.</td>
<td>11<linkhtml href="#footnote-6">#</linkhtml>
<br/>
<br/>
<br/>15</td>
<td>↓ <br/>
<br/>
<br/>↓</td>
<td>0.60 <br/>(0.56–0.64) <br/>
<br/>0.53 <br/>(0.47–0.59)</td>
<td>0.60 <br/>(0.57–0.63) <br/>
<br/>0.49 <br/>(0.43–0.55)</td>
<td>0.58 <br/>(0.52–0.64) <br/>
<br/>0.42 <br/>(0.35–0.51)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With Other Drugs</content>
</td>
</tr>
<tr>
<td>Artemether/ Lumefantrine</td>
<td>80/480 mg (6 doses at 0, 8, 24, 36, 48, and 60 hours) </td>
<td>600/100 mg b.i.d.</td>
<td>14</td>
<td>↔</td>
<td>1.00<br/>(0.93–1.07)</td>
<td>0.96<br/>(0.90–1.03)</td>
<td>0.87<br/>(0.77–0.98)</td>
</tr>
<tr>
<td>Carbamazepine</td>
<td>200 mg b.i.d.</td>
<td>600/100 mg b.i.d.</td>
<td>16</td>
<td>↔</td>
<td>1.04<br/>(0.93–1.16)</td>
<td>0.99<br/>(0.90–1.08)</td>
<td>0.85<br/>(0.73–1.00)</td>
</tr>
<tr>
<td>Clarithromycin</td>
<td>500 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>17</td>
<td>↔</td>
<td>0.83<br/>(0.72–0.96)</td>
<td>0.87<br/>(0.75–1.01)</td>
<td>1.01<br/>(0.81–1.26)</td>
</tr>
<tr>
<td>Ketoconazole</td>
<td>200 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>14</td>
<td>↑</td>
<td>1.21<br/>(1.04–1.40)</td>
<td>1.42<br/>(1.23–1.65)</td>
<td>1.73<br/>(1.39–2.14)</td>
</tr>
<tr>
<td>Omeprazole</td>
<td>20 mg q.d.</td>
<td>400/100 mg b.i.d.</td>
<td>16</td>
<td>↔</td>
<td>1.02<br/>(0.95–1.09)</td>
<td>1.04<br/>(0.96–1.13)</td>
<td>1.08<br/>(0.93–1.25)</td>
</tr>
<tr>
<td>Paroxetine</td>
<td>20 mg q.d.</td>
<td>400/100 mg b.i.d.</td>
<td>16</td>
<td>↔</td>
<td>0.97<br/>(0.92–1.02)</td>
<td>1.02<br/>(0.95–1.10)</td>
<td>1.07<br/>(0.96–1.19)</td>
</tr>
<tr>
<td>Ranitidine</td>
<td>150 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>16</td>
<td>↔</td>
<td>0.96<br/>(0.89–1.05)</td>
<td>0.95<br/>(0.90–1.01)</td>
<td>0.94<br/>(0.90–0.99)</td>
</tr>
<tr>
<td>Rifabutin</td>
<td>150 mg q.o.d. <linkhtml href="#footnote-7">Þ</linkhtml>
</td>
<td>600/100 mg b.i.d.</td>
<td>11</td>
<td>↑</td>
<td>1.42<br/>(1.21–1.67)</td>
<td>1.57<br/>(1.28–1.93)</td>
<td>1.75<br/>(1.28–2.37)</td>
</tr>
<tr>
<td>Sertraline</td>
<td>50 mg q.d.</td>
<td>400/100 mg b.i.d.</td>
<td>13</td>
<td>↔</td>
<td>1.01<br/>(0.89–1.14)</td>
<td>0.98<br/>(0.84–1.14)</td>
<td>0.94<br/>(0.76–1.16)</td>
</tr>
</tbody>
</table>